e-learning
resources
Munich 2006
Monday 04.09.2006
Biology and prognostic factors
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Adenoviral transduction of MRP-1/CD9 and KAI-1/CD82 inhibits lymph node metastasis in orthotopic lung cancer model
N. Hattori, T. Takeda, M. Miyake, N. Kohno (Hiroshima, Kobe, Osaka, Japan)
Source:
Annual Congress 2006 - Biology and prognostic factors
Session:
Biology and prognostic factors
Session type:
Poster Discussion
Number:
2302
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Hattori, T. Takeda, M. Miyake, N. Kohno (Hiroshima, Kobe, Osaka, Japan). Adenoviral transduction of MRP-1/CD9 and KAI-1/CD82 inhibits lymph node metastasis in orthotopic lung cancer model. Eur Respir J 2006; 28: Suppl. 50, 2302
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Optimizing invasive ventilation for SMA type 1 children who are receiving the gene therapy
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Related content which might interest you:
PD-L1 expression on lung cancer stem cells in metastatic lymph nodes.
Source: International Congress 2018 – Lung cancer: new aspects in diagnosis and management
Year: 2018
Splenectomy inhibits tumor development and metastases in murine lung cancer models
Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer
Year: 2012
Correlation between p53 expression in bronchus biopsies from non-small cell lung cancer cases and mediastinal lymph node invasion demonstrated through mediastinoscopy
Source: Eur Respir J 2006; 28: Suppl. 50, 82s
Year: 2006
An usual metastasis of squamous cell lung cancer: intra-abdominal lymph nodes
Source: Annual Congress 2009 - Clinical aspects and epidemiology in lung cancer
Year: 2009
EVI5 is an oncogene that regulates the proliferation and metastasis of NSCLC cells
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020
Central tumor location and presence of occult lymph node metastasis in cT1N0M0 NSCLC
Source: International Congress 2019 – Diagnosis of lung cancer
Year: 2019
Inhibition of tumor growth and metastatic lung tumors in mice by adenovirus-mediated interferon-β gene therapy
Source: Eur Respir J 2003; 22: Suppl. 45, 199s
Year: 2003
Telomerase activity, micrometastasis and lynphonodal metastasis in resected non small cell lung cancer
Source: Annual Congress 2008 - Diagnosis and prognosis in thoracic oncology
Year: 2008
ADAM9 enhances CDCP1 protein expression by suppressing miR-218 for lung tumour metastasis
Source: International Congress 2016 – Basic science and case reports in lung cancer
Year: 2016
IGF1R facilitates implantation and progression of lung metastasis acting in the tumor microenvironment
Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research
Year: 2021
The affect of the metabolic activity of the primary tumor to lymph node and distant metastasis in non-small cell lung cancer
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
Recruitment of podoplanin positive cancer-associated fibroblasts in metastatic lymph nodes predicts poor prognosis in pathological N2 stage III lung adenocarcinoma
Source: Annual Congress 2012 - Prognosis of lung cancer
Year: 2012
Determination of distant metastases in non-small cell lung cancer and factors related to presence of metastasis
Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology
Year: 2008
Gene expression of lung squamous cell carcinoma reflects mode of lymph node involvement
Source: Eur Respir J 2007; 30: 21-26
Year: 2007
Adenylate cyclase-associated protein 1 is associated with metastasis of non-small cell lung cancer especially in brain metastasis patients and promotes the lung cancer cell proliferation and migration in vitro as well as its growth and metastasis in vivo by the signaling pathways of limk1-cofilin
Source: International Congress 2015 – New frontiers in biomedical research on thoracic tumours
Year: 2015
Immunomodulating properties of PD-L1 positive cancer stem cells in metastatic lymph nodes
Source: International Congress 2019 – Diagnostic procedures and biology of lung cancer
Year: 2019
Prognostic relevance of angiogenesis in stage III NSCLC receiving multimodality treatment
Source: Eur Respir J 2009; 33: 1383-1388
Year: 2009
T cell maturation profile in metastatic vs. non-metastatic lymph nodes in NSCLC patients
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Year: 2021
Different morphological changes in non-small cell lung cancers and their corresponding lymph node metastases after neoadjuvant therapy?
Source: Eur Respir J 2004; 24: Suppl. 48, 479s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept